Bicycle Therapeutics plc
BCYCNASDAQHealthcare● Active
$4.11
$-0.09(-2.14%)
Market Cap$285211539
P/E Ratio—
52W High$9.36
52W Low$4.09
Bicycle Therapeutics plc (BCYC) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BCYC · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $72.59M | $35.27M | $26.98M | $14.46M | $11.70M |
| Cost of Revenue | $0.00M | $172.97M | $156.50M | $0.00M | $0.00M |
| Gross Profit | $72.59M | ($137.69M) | ($129.52M) | $14.46M | $11.70M |
| Gross Margin %(computed) | 100.00% | -390.34% | -480.13% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $240.28M | $172.97M | $156.50M | $81.61M | $44.88M |
| G&A Expenses | $80.02M | $71.46M | $59.83M | $49.51M | $32.44M |
| Total Operating Expenses | $320.30M | $72.18M | $60.43M | $131.12M | $77.31M |
| Operating Income | ($247.72M) | ($209.87M) | ($189.95M) | ($116.65M) | ($65.62M) |
| Operating Margin %(computed) | -341.28% | -594.96% | -704.13% | -806.56% | -560.98% |
| Interest Income | $28.46M | $34.28M | $14.00M | $5.76M | $0.12M |
| Interest Expense | $0.21M | $1.73M | $3.26M | $3.34M | $2.98M |
| Income Before Tax | ($218.81M) | ($173.80M) | ($179.21M) | ($114.24M) | ($68.48M) |
| Income Tax Expense | $0.15M | ($4.76M) | $1.46M | ($1.52M) | ($1.66M) |
| Net Income | ($218.96M) | ($169.03M) | ($180.66M) | ($112.72M) | ($66.82M) |
| Net Margin %(computed) | -301.66% | -479.18% | -669.72% | -779.35% | -571.25% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-3.16 | $-2.91 | $-5.08 | $-3.80 | $-2.67 |
| Wtd Avg Shares | 69.28M | 58.21M | 35.59M | 29.66M | 25.06M |
| EBITDA | ($212.18M) | ($164.89M) | ($183.40M) | ($107.21M) | ($64.09M) |
| EBITDA Margin %(computed) | -292.32% | -467.45% | -679.86% | -741.26% | -547.91% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Bicycle Therapeutics plc data
About Bicycle Therapeutics plc (BCYC) Income Statement
Bicycle Therapeutics plc (BCYC) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BCYC reported revenue of $0.07B, gross profit of $0.07B (gross margin 100.00%), and net income of ($0.22B) — a net profit margin of -301.66%.
Frequently asked questions
BCYC · 4 questionsBicycle Therapeutics plc (BCYC) reported revenue of $0.07B for 2025, up 105.8% year-over-year.
BCYC revenueBCYC salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08